Storage Condition
Refer MSDS for complete information
Synonyms
Anidulafungin-d11, 1123186-04-8
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Anidulafungin-d11 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Anidulafungin-d11 usage and description
Anidulafungin-d11 is a deuterated form of the antifungal drug Anidulafungin. It is primarily used for the treatment of invasive candidiasis, a fungal infection that affects individuals with a weakened immune system. Anidulafungin-d11 is administered intravenously and works by inhibiting the synthesis of beta (1,3)-D-glucan, an essential component of the fungal cell wall. This action weakens the cell wall, causing the fungal cells to rupture and die.
Anidulafungin-d11 is a semisynthetic echinocandin and is chemically described as (3S,6S,9S,11R,15S,20R,21S,23S,24E,26E,28E,30S,32S,35R)-21-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-32-[(1S)-1-[(4R)-4-hydroxy-4-[4-(pentyloxy)phenyl]-1-piperidinyl]ethyl]-28-methyl-3,6,20,21,23,24,26,30,32,35-decaazatricyclo[30.3.1.0~4,9~]hexatriaconta-4,6,11,15,23-pentaene-2,25-dione.
Anidulafungin-d11 has a molecular formula of C58H73D11N11O17 and a molecular weight of 1245.38 g/mol. It is administered as a lyophilized powder that is reconstituted with sterile water for injection. Anidulafungin-d11 has a half-life of approximately 24 hours and is primarily eliminated through hepatic metabolism.
Overall, Anidulafungin-d11 is a potent antifungal drug that is effective in treating invasive candidiasis. Its chemical structure and mechanism of action make it a valuable addition to the arsenal of drugs used to combat fungal infections.
